Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
Certified by Founder
Lodge
Alkemi Growth Capital
start up
India
- New Delhi, Delhi
- 05/09/2022
- Series C
- $44,000,000
At Alkemi, our mission is to elevate the Health and Well-Being of the Indian consumer while maximizing returns to our shareholders.
We are interested in passionate entrepreneurs who are inspired by a vision, have boldness in their DNA, are not afraid of taking a few punches, persevere under uncertainty and most importantly build companies that can make an out-sized difference to consumer wellness and healthcare industry. If you are such an entrepreneur, we would love to talk to you. Please reach out to: sayhello@alkemivp.com
- Industry Venture Capital and Private Equity Principals
- Website https://www.alkemivp.com/
- LinkedIn https://www.linkedin.com/company/alkemi-growth-capital/
Related People
Alka GoelInvestor
India -
New Delhi, Delhi
Alkemi's raison d^etre is to be a growth catalyst today for tomorrow's greatest companies that meaningfully elevate the well-being of the Indian consumer.
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)